The choice of safe and highly effective contraception for women who have special medical conditions can pose tremendous challenges. Viral hepatitis such as hepatitis C virus (HCV) is a major public ...

The legal landscape surrounding Depo-Provera, a long-acting injectable birth control, has entered a pivotal phase. With the growing number of lawsuits alleging that the drug caused serious brain ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Depo-Provera, a commonly used injectable contraceptive, has been linked to an increased risk of meningiomas, which are a type of brain tumor. If you or someone you know has been diagnosed with a ...

WASHINGTON — The Clinton Health Access Initiative, working with the Gates Foundation and a host of foreign-aid agencies, including USAID, distributes millions of doses of birth-control injections to ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.

The motion cites 22 cases, most in California, filed against brand manufacturer Pfizer Inc. and authorized generic providers. The motion says most of the plaintiffs will be in Massachusetts or ...

Advertisements on the TV news lately have been citing a 2004 lawsuit against Pfizer (where have I heard that name?) over potentially causing a form of brain cancer with its readily available ...

When many women turned to Depo-Provera as a convenient birth control option, they had no idea it might carry life-altering risks. After years of injections, some began experiencing troubling symptoms ...

The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...

Medroxyprogesterone acetate 104mg/0.65mL; SC inj; contains parabens. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation ...